Fortress Biotech (FBIO) FCF Margin (2015 - 2025)
Fortress Biotech (FBIO) posted quarterly FCF Margin of 89.24% for Q4 2025, down 411.0% year-over-year from 28.7% in Q4 2024, and down 157.52% quarter-over-quarter from 34.65% in Q3 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) FCF Margin (2015 - 2025) Analysis & Trends
Fortress Biotech's FCF Margin history runs 11 years deep, the most recent figure standing at 89.24% for Q4 2025.
- In Q4 2025, FCF Margin fell 411.0% year-over-year to 89.24%; the TTM figure through Dec 2025 stood at 109.93% (up 2901.0% YoY), while the FY2025 annual figure was 107.41%, up 3163.0% from the prior year.
- FCF Margin for Q4 2025 stood at 89.24%, down from 34.65% in the prior quarter.
- The five-year high for FCF Margin was 87.96% in Q4 2022, with the low at 23266.45% in Q2 2021.
- The 5-year median for FCF Margin is 189.23% (2025), against an average of 3759.46%.
- The sharpest annual moves came in 2021 and 2022: FCF Margin plunged 2308655 bps in 2021, then soared 2303760 bps in 2022.
- Fortress Biotech's FCF Margin stood at 69.51% in 2021, then jumped by 227 bps to 87.96% in 2022, then plunged by 361 bps to 229.16% in 2023, then soared by 63 bps to 85.13% in 2024, then declined by 5 bps to 89.24% in 2025.
- Business Quant data shows FBIO's FCF Margin at 89.24% in Q4 2025, 34.65% in Q3 2025, and 183.62% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 70.82% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -22.35% |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -78.01% |
| Sep 30, 2025 | -34.65% |
| Jun 30, 2025 | -167.92% |
| Mar 31, 2025 | -148.89% |
| Dec 31, 2024 | -85.36% |
| Sep 30, 2024 | -127.58% |
| Jun 30, 2024 | -155.97% |
| Mar 31, 2024 | -194.83% |
| Dec 31, 2023 | -175.29% |
| Sep 30, 2023 | -48.28% |
| Jun 30, 2023 | -191.57% |
| Mar 31, 2023 | -347.88% |
| Dec 31, 2022 | -292.22% |
| Sep 30, 2022 | -267.75% |
| Jun 30, 2022 | -228.85% |
| Mar 31, 2022 | -201.45% |
| Dec 31, 2021 | -222.44% |
| Sep 30, 2021 | -105.08% |
| Jun 30, 2021 | -202.11% |
| Mar 31, 2021 | -191.88% |